Mischi a Marca

Partner
Full contact info

Experience

Xometry – $287 Million Convertible Senior Notes Offering

February 24, 2022

Cooley advised Xometry on its offering of $287.5 million aggregate principal amount of 1% convertible senior notes due 2027. Partners Eric Blanchard, Mischi a Marca and Jason Savich led the Cooley team advising Xometry, which provides AI-enabled manufacturing equipment.

Related contacts

Eric Blanchard
Partner, Boston
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Trey Reilly
Associate, New York
Nicholas Balenger
Associate, Reston

Related Practices & Industries

Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III

December 16, 2021

Cooley advised Biote, a medical practice-building business within the hormone optimization space, on its definitive business combination agreement with special purpose acquisition company (SPAC) Haymaker Acquisition Corp III. Lawyers Michal Berkner and Jarrett Burks led the Cooley team advising Biote.

Related contacts

Jarrett Burks
Associate, London
Ryan Sansom
Partner, Boston
Meg Begur
Associate, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Eileen Marshall
Partner, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Sonia Nath
Partner, Washington, DC
Michael Tollini
Partner, Washington, DC
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, Colorado
Mischi a Marca
Partner, San Francisco
Kathleen Goodhart
Partner, San Francisco
Ehijele Olumese
Associate, Santa Monica
Francis Wheeler
Partner, Colorado
Claire Keast-Butler
Co-Partner in Charge – London, London
Andrew Epstein
Special Counsel, Seattle
Todd Gluth
Partner, San Diego
Joseph Lockinger
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
David Hopkins
Special Counsel, Colorado
Ross Eberly
Partner, Santa Monica

Related Practices & Industries

Global Blood Therapeutics – $345 Million Convertible Senior Notes Offering

January 4, 2022

Cooley advised the initial purchasers on Global Blood Therapeutics’ Rule 144A offering of $345 million aggregate principal amount of 1.875% Convertible Senior Notes due 2028.  In connection with the offering, GBT entered into capped call transactions. Goldman Sachs & Co. and Jefferies acted as joint book-running managers for the offering. Global Blood Therapeutics is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Partners Kristin VanderPas, Charlie Kim, Dave Peinsipp, Mischi a Marca and Jason Savich led the Cooley team.

Related contacts

Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Denny Won
Partner, San Francisco
Kyle Huh
Associate, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles
Jessica Wade
Paralegal Specialist, San Diego
Timothy Nguyen
Special Counsel, San Francisco
Ellie Seber
Partner, Santa Monica

Related Practices & Industries

Dynavax Technologies – $200 Million Convertible Notes Offering

May 11, 2021

Cooley advised Dynavax Technologies on its offering of $200 million principal amount of 2.50% convertible senior notes due 2026. Dynavax Technologies, whose securities trade on the Nasdaq Capital Market under the symbol DVAX, is a biopharmaceutical company focused on developing and commercializing novel vaccines. Partners Steve Przesmicki, Mischi a Marca and Jason Savich le the Cooley team.

Related contacts

Steve Przesmicki
Partner, San Diego
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Marina Remennik
Special Counsel, Palo Alto
Ron Metzger
Paralegal Specialist, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Ellie Seber
Partner, Santa Monica
Matt Kong
Associate, San Francisco
Xueqing Li
Associate, San Francisco
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

Confluent – $1.1 Billion Convertible Senior Notes Offering

January 14, 2022

Cooley advised Confluent on its offering of $1.1 billion aggregate principal amount of 0.00% convertible senior notes due 2027. Confluent has pioneered a new category of data infrastructure designed to connect all the applications, systems and data layers of a company around a real-time central nervous system. Partners Mischi a Marca, Jason Savich, Jon Avina, Milson Yu and Siana Lowrey led the Cooley team.

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Jon Avina
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Siana Lowrey
Of Counsel
Ellie Seber
Partner, Santa Monica
Timothy Nguyen
Special Counsel, San Francisco
Nikki Chang
Associate, Palo Alto
Eric Steiner
Paralegal Specialist, San Francisco

Related Practices & Industries

View more

Admissions and credentials

California

New York

Rankings and accolades

Chambers USA: Band 1 for Capital Markets: Convertible Debt – Nationwide (2021 – 2024)

Chambers USA: Capital Markets: Debt & Equity: Western United States – Nationwide (2021 – 2024)

Chambers USA: Capital Markets: Debt & Equity – California (2021 – 2024)